Mechanisms of allergy and clinical immunologyBlood DNA methylation biomarkers predict clinical reactivity in food-sensitized infants
Section snippets
Sample population
We obtained blood samples from the HealthNuts study in Melbourne, Australia, a population-based study of infant FA.11 These samples were collected from 11- to 15-month-old infants who underwent SPTs to egg white, peanut, and 1 of 2 other foods (cow's milk or shrimp) and had undergone objective OFCs yielding definitive phenotyping data.12 Although egg allergy is the most common form of FA in early childhood,1 it has the highest rate of resolution,8 whereas peanut allergy is unlikely to resolve9
Clinical features of the sample population
For this study, we selected subjects monosensitized to either egg or peanut to represent both the common and severe forms of FA, respectively. Genome-scale methylation analysis was performed on PBMCs from 58 food-sensitized subjects (aged 11-15 months), half of whom were clinically reactive based on OFC results. Thirteen nonsensitized nonallergic control subjects were also assessed. We divided patients into major subgroups according to their food challenge outcome, as shown in Table I.
Discussion
Biomarkers of FA are urgently needed to develop more powerful diagnostic tools that identify bona fide FA against a background of FS. Here we have developed a multivariate classifier model with utility for predicting food challenge outcomes. Different subtypes of FA exist, and we have shown that pattern-finding computational methods perform extremely well when prior knowledge of these subtypes are available. The strength of this approach is rooted in the definitive food challenge outcome data,
References (25)
- et al.
Epigenetics in immune development and in allergic and autoimmune diseases
J Reprod Immunol
(2014) - et al.
Early clinical predictors of remission of peanut allergy in children
J Allergy Clin Immunol
(2008) - et al.
Further fatal allergic reactions to food in the United Kingdom, 1999-2006
J Allergy Clin Immunol
(2007) - et al.
Predetermined challenge eligibility and cessation criteria for oral food challenges in the HealthNuts population-based study of infants
J Allergy Clin Immunol
(2012) - et al.
Skin prick test responses and allergen-specific IgE levels as predictors of peanut, egg, and sesame allergy in infants
J Allergy Clin Immunol
(2013) - et al.
Increasing the accuracy of peanut allergy diagnosis by using Ara h 2
J Allergy Clin Immunol
(2012) - et al.
Prevalence of challenge-proven IgE-mediated food allergy using population-based sampling and predetermined challenge criteria in infants
J Allergy Clin Immunol
(2011) - et al.
Food allergy: riding the second wave of the allergy epidemic
Pediatr Allergy Immunol
(2011) Diagnosis of food allergies: the impact of oral food challenge testing
Asia Pac Allergy
(2013)- et al.
Food allergy and anaphylaxis in pediatrics: update 2010-2012
Pediatr Allergy Immunol
(2012)
Epigenome-wide association studies for common human diseases
Nat Rev Genet
Epigenome-wide association study reveals longitudinally stable DNA methylation differences in CD4+ T cells from children with IgE-mediated food allergy
Epigenetics
Cited by (81)
The pathogenesis of food allergy and protection offered by dietary compounds from the perspective of epigenetics
2024, Journal of Nutritional BiochemistryDNA methylation profiling reveals potential biomarkers of β-lactams induced fatal anaphylactic shock
2024, Forensic Science InternationalThe role of air pollution in fetal origins of childhood allergy: Challenges and opportunities
2023, Current Opinion in Environmental Science and HealthMulti-omics profiling approach in food allergy
2023, World Allergy Organization JournalAllergies to food and airborne allergens in children and adolescents: role of epigenetics in a changing environment
2022, The Lancet Child and Adolescent Health
Supported by the CASS Foundation (SM/11/3647/RMR:DSA), the DHB Foundation (CT21242), and the NHMRC (1072752).
Disclosure of potential conflict of interest: This study was funded by the CASS Foundation, DHB Foundation, and the National Health and Medical Research Council, Australia's leading expert body promoting the development and maintenance of public and individual health standards. S. Prescott has received compensation for board membership from Danone Nutricia and the Nestlè Nutrition Institute, has received payment for delivering lectures from Danone Nutricia and the Nestlè Nutrition Institute, and receives royalties from UpToDate. M. L. K. Tang has received compensation for board membership from Danone Nutricia and the Nestlè Nutrition Institute; has received payment for delivering lectures from Danone Nutricia and the Nestlè Nutrition Institute; and has received compensation for travel and other meeting-related expenses from APARPI. A.-L. Ponsonby is employed by the NHMRC, from which she has also received or has grants pending. K. J. Allen has received consultancy fees from Nutricia, Danone, Nestlè, Aspen, and Alphapharm. The rest of the authors declare that they have no relevant conflicts of interest.
- ∗
These author contributed equally to this work.